Advanced Search

 

Study ID Status Title Patient Level Data
113393 Withdrawn An Open Label, Single dose, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK2248761 200 mg, Administered as an Oral Suspension to Healthy Adult Subjects
113394 Terminated A Double-Blind study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Drospirenone and Ethinyl Estradiol when Co-administered with GSK2248761 in Healthy Adult Female Subjects
113398 Completed Consistency of immunogenicity and non inferiority of three production lots of GSK Biologicals’ candidate malaria vaccine in children Study Listed on ClinicalStudyDataRequest.com
113399 Terminated A Phase 2b study to select a once daily oral dose of GSK2248761 in HIV-1 infected antiretroviral therapy experienced adults with non-nucleoside reverse transcriptase inhibitor (NNRTI) resistance
113404 Terminated Phase 2b study to select a once daily oral dose of GSK2248761 administered with tenofovir/emtricitabine or abacavir/lamivudine in HIV-1 infected antiretroviral therapy naive adult subjects
113405 Completed Special Drug Use Investigation for ADOAIR Metered-dose Inhaler (Pediatric)
113406 Completed Special Drug Use Investigation for ALLERMIST (Long term)
113407 Completed Drug Use Investigation for ALLERMIST
113412 Completed An open-label single dose randomized, parallel group study followed by single-blind repeat dosing, to compare the relative bioavailability of GSK2212836 Study Listed on ClinicalStudyDataRequest.com
113413 Active, not recruiting A Multicentre, Open-Label, Long-Term, Safety and Tolerability Study of Retigabine Immediate Release (IR) in Adults with Partial-Onset Seizures (Extension of Study RGB113905)
113414 Completed A Randomized, Double Blind, Double Dummy Multicenter Phase IIa Study to Assess Safety, Tolerability and Efficacy of GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection Study Listed on ClinicalStudyDataRequest.com
113417 Completed Insulin resistance as primary pathogenesis in newly diagnosed, drug naïve type 2 diabetes patients in Korea
113423 Completed A randomised, double-blind, double-dummy, single dose, four way cross-over study to compare the pharmacokinetics and pharmacodynamics of GSK961081 and fluticasone propionate when administered alone, concurrently and as a combination blend in healthy subjects Study Listed on ClinicalStudyDataRequest.com
113434 Completed A randomised, double-blind, placebo-controlled study of topical GW870086X formulation in subjects with moderate or severe atopic dermatitis Study Listed on ClinicalStudyDataRequest.com
113435 Completed A randomised, double-blind (for GW870086), placebo-controlled study of topical GW870086 formulation to explore the potential for skin thinning in healthy adult volunteers Study Listed on ClinicalStudyDataRequest.com
113440 Completed A study to evaluate the safety and immunogenicity of A/California/7/2009 (H1N1)v-like vaccines GSK2340273A and GSK2340274A in adults aged 18 years and older Study Listed on ClinicalStudyDataRequest.com
113445 Completed NUTRItional Adequacy Therapeutic Enhancement in the critically ill: A randomized double blind, placebo-controlled trial of the motilin receptor agonist GSK962040. The NUTRIATE Study
113456 Completed Safety and immunogenicity study of GSK Biologicals’ influenza vaccine GSK2340272A in adults aged 18 to 60 years Study Listed on ClinicalStudyDataRequest.com
113459 Completed Safety and immunogenicity study of GSK Biologicals’ influenza vaccine GSK2340272A in adults aged 18 years and above Study Listed on ClinicalStudyDataRequest.com
113462 Completed Safety and immunogenicity study of GSK Biologicals’ pandemic influenza candidate vaccine (GSK2340272A) in children aged 6 to 35 months Study Listed on ClinicalStudyDataRequest.com
113463 Completed An Open-Label Study to Characterize the Absorption, Distribution, Metabolism and Elimination of a Single Oral 14C Labeled Dose of GSK2118436 in Subjects with BRAF Mutant Solid Tumors
113468 Completed An Open-Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects with BRAF Mutation-Positive Tumor
113476 Completed A study to investigate the psychomotor and cognitive effects of alcohol when co-administered with GSK1144814 or matching placebo in healthy subjects.
113477 Completed An open-label, randomised, two-way crossover study, to evaluate and compare the pharmacokinetics of fluticasone furoate, administered from a novel dry powder device (repeat dose) and intravenously (single dose), in healthy Caucasian, Japanese, Korean and Chinese subjects Study Listed on ClinicalStudyDataRequest.com
113479 Completed Determination of the Absolute Bioavailability of GSK2118436 Following a Single Oral Dose Co-Administered with an Intravenous Radiolabelled Microtracer of GSK2118436 in Subjects with BRAF Mutant Solid Tumors

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.